The science behind the silent killer. Here is how Inimmune is developing vaccines to help solve the opioid epidemic.
Read full article:
Recent Posts
- Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
- Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm
- Montana Biotech Company Receives $2 M Small Business Innovation Research Grant to Advance Vaccine Technologies
- Development of COVID-19 Vaccine, Tests Advancing in Montana
- Science Behind the Silent Killer